Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1969 1
1975 1
1978 1
1982 1
1994 1
1998 1
1999 3
2001 3
2002 3
2003 3
2004 2
2005 5
2006 5
2007 4
2008 6
2009 2
2010 7
2011 7
2012 13
2013 13
2014 14
2015 12
2016 22
2017 16
2018 21
2019 16
2020 11
2021 10
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 22782312

192 results

Results by year

Filters applied: . Clear all
Page 1
Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesions.
van Vliet EI, Hermans JJ, de Ridder MA, Teunissen JJ, Kam BL, de Krijger RR, Krenning EP, Kwekkeboom DJ. van Vliet EI, et al. J Nucl Med. 2012 Sep;53(9):1359-66. doi: 10.2967/jnumed.112.102871. Epub 2012 Jul 10. J Nucl Med. 2012. PMID: 22782312 Free article.
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P, Ranade R, Ostwal V, Shrikhande SV, Goel M, Basu S. Thapa P, et al. Nucl Med Commun. 2016 Oct;37(10):1030-7. doi: 10.1097/MNM.0000000000000547. Nucl Med Commun. 2016. PMID: 27243215
Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases.
Limouris GS, Poulantzas V, Trompoukis N, Karfis I, Chondrogiannis S, Triantafyllou N, Gennimata V, Moulopoulou LE, Patsouris E, Nikou G, Michalaki V, Fragulidis G, Paphiti M, McCready RV, Colletti PM, Cook GJ, Rubello D. Limouris GS, et al. Clin Nucl Med. 2016 Mar;41(3):194-200. doi: 10.1097/RLU.0000000000001096. Clin Nucl Med. 2016. PMID: 26673241
192 results